Histamine downregulates monocyte CCL2 production through the histamine H4 receptor
Dorothea Dijkstra(Medizinische Hochschule Hannover), Ralf Gutzmer(Medizinische Hochschule Hannover), Fiona C. Shenton(Durham University), Rob Leurs(University of Hong Kong), Holger Stark(Goethe University Frankfurt), Paul L. Chazot(University of Helsinki), Thomas Werfel(Medizinische Hochschule Hannover)
Cited by 129
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
|Allergy|2014|1k
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476